ResMed (NYSE: RMD) has outperformed the market over the past 10 years by 2.9% on an annualized basis producing an average annual return of 16.12%. Currently, ResMed has a market capitalization of ...
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, ...
That’s been the question floating around ResMed’s (ASX:RMD) HQ for the past five years, given its obstructive sleep apnea (OSA) therapy rival’s absence from the US device market owing to a product ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. ResMed (RMD) is back in focus after reporting higher sales and net income for ...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. If you are wondering whether ResMed's current share price lines up with its underlying worth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results